The pharmaceutical death-ride of dihydroartemisinin

Frans Herwig Jansen | 22 Jul 2010 | Malaria Journal

In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies.

China's Billion-Dollar Aid Appetite

Jack C. Chow | 19 Jul 2010 | Foreign Policy

Back in 2001, I was the lead U.S. negotiator in international talks meant to transform the way that poor countries fight some of the world's most pernicious diseases — HIV/AIDS, tuberculosis, and malaria.

Gates grant funds production of genetically engineered malaria drug

Kristi Heim | 08 Jul 2010 | Seattle Times

The Institute for OneWorld Health, a San Francisco-based nonprofit, said it has received $10.7 million from the Gates Foundation to begin commercial production of a key ingredient for malaria treatment.

Malaria Drug Resistance in Cambodia Not a Surprise

Joe De Capua | 06 Jul 2010 | Voice of America

Health officials in Cambodia have found a strain of malaria that's showing resistance to the main anti-malaria drug, known as artemisinin. Resistance means patients can take longer to recover.

AFRICA: Most paediatric fevers not caused by malaria

None | 06 Jul 2010 | IRIN News

More than half the paediatric fevers treated in public health clinics in Africa are caused by diseases other than malaria, according to a study by Oxford University and other research groups, whose authors caution against the "continued indiscriminate use of anti-malarials for all fevers across Africa."

War On Counterfeit Drugs Still On

Gasirigwa Sengiyumva | 05 Jul 2010 | Tanzania Daily News

The issue of substandard and counterfeit medicines remain a huge problem, not only to sub- Saharan Africa as a whole but also to this country in particular. This is an appalling situation that proves fatal for some of the world's poorest, most vulnerable people.

Mens sana in corpore sano

None | 01 Jul 2010 | Economist

Human intelligence is puzzling. It is higher, on average, in some places than in others. And it seems to have been rising in recent decades. Why these two things should be true is controversial.

Fake Drugs A Global Health Threat

Talea Miller | 24 Jun 2010 | PBS NewsHour

Fake drugs manufactured to resemble dozens of well-known pharmaceutical brands are making their way across international borders and threatening lives, the World Customs Organization said Thursday.

Report Optimistic on Africa Economies

Celia Dugger | 23 Jun 2010 | New York Times

Africa is often depicted as a place of war, disease and poverty, with a begging bowl extended to the world. But a new report paints a much more optimistic portrait of a continent with growing national economies and an expanding consumer class that offers foreign investors the highest rates of return in the developing world.

Fear as a bar to progress

Temba Nolutshungu | 22 Jun 2010 | Washington Times

Africans already suffer from the Euro- pean Union's bureaucratic ideology known as the "precautionary prin- ciple." As the EU's economies teeter on the brink, fettered by bloated and inefficient government policies, the United States is in danger of importing this idea. It is bad for Americans and bad for the world's poor.